Elif Ekinci
The University of Melbourne, VIC, Australia
- This delegate is presenting an abstract at this event.
Dr Elif Ekinci is an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. She is the Sir Edward Dunlop Medical Research Foundation Senior Fellow in Metabolic Medicine at The University of Melbourne, Department of Medicine, Austin Health. Her research focus is diabetes and its complications, aiming to significantly improve clinical practice and health outcomes. Her research streams include the following:
(i) effects of diabetes on kidney function
(ii) effects of dietary sodium intake in people with diabetes
(iii) improving the management of diabetes in the inpatient setting
(iv) improving the management of diabetes for Indigenous Australians living in remote and rural communities
(v) effects of pre-existing diabetes on pregnancy
She is also the Director of Diabetes at Austin Health where she co-ordinates the clinical care of inpatients and outpatients with diabetes. She heads Diabetes and Obesity clinical trials at Austin Health and The University of Melbourne where she is the Chief Investigator in numerous clinical trials.
Dr Ekinci has 65 publications including in the following journals: Diabetes Care, Diabetes, Diabetologia, Clinical Science, Diabetic Medicine, AJKD, Kidney International, MJA. She has co-authored more than 100 abstracts at various national and international meetings. She supervises PhD students and MDRP students and also mentors endocrinologists, endocrine registrars, residents, interns, medical students and clinical trials staff. She has obtained a total of over $4 million of research funding along with her colleagues, including funding from the NHMRC.
Presentations this author is a contributor to:
Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function (#14)
10:30 AM
Elif I Ekinci
ADS Clinical Orals - Complications 1: Eyes, Kidneys and Feet
Relationship between 24h urinary sodium-to-potassium ratio with blood pressure and renin angiotensin aldosterone activity in people with diabetes (#345)
2:00 PM
Renata Libianto
ADS Clinical Poster Discussions